AEye Health receives FDA clearance for the detection of more than mild to moderate diabetic retinopathy – a first for our clinical trials program
For Immediate Release AEye Health, a Tel Aviv biotechnology firm, received FDA clearance for use of the AEYE-DS tool for the detection of more-than-mild diabetic retinopathy with the Topcon NW400…
